Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Jacobson

Showing results (101-110 of 161) with videos related to

Pageof 17
Sort By:
The Journal of Endocrinology|July 1, 1989
Opioid receptors on cells of the immune system: evidence for delta- and kappa-classesD J Carr, B R DeCosta, C H Kim, et al.
Peptides|November 1, 1992
Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that mu ligands are noncompetitive inhibitors of the delta cx opioid peptide binding siteR B Rothman, A Mahboubi, V Bykov, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2000
N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindoleA Coop, A E Jacobson, M D Aceto, et al.
European Journal of Pharmacology|June 8, 1989
Metaphit, an isothiocyanate analog of PCP, induces audiogenic seizures in miceE A Debler, M N Lipovac, A Lajtha, et al.
NIDA Research Monograph|January 1, 1986
Upregulation of the mu-noncompetitive delta binding site by chronic morphine administration: effect of preincubating membranes in 400 nM sodium chlorideJ A Danks, F C Tortella, V Bykov, et al.
Journal of Pharmaceutical Sciences|March 1, 1987
2,5-Dimethyl-2'-hydroxy-9 alpha- and 9 beta-(3-methylbutyl)-6,7-benzomorphans and N-substituted compounds in the 9 alpha-(3-methylbutyl) series: chemistry, pharmacology, and biochemistryA E Jacobson, K C Rice, T R Burke, et al.
Arzneimittel-Forschung|January 1, 1983
Zomepirac: preclinical narcotic abuse liability evaluationJ H Woods, A M Young, F Medzihradsky, et al.
Neuropeptides|October 1, 1988
A brief study of the selectivity of norbinaltorphimine, (-)-cyclofoxy, and (+)-cyclofoxy among opioid receptor subtypes in vitroR B Rothman, V Bykov, A Reid, et al.
European Journal of Pharmacology|January 24, 1989
Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sitesR B Rothman, V Bykov, J B Long, et al.
Brain Research|July 9, 1990
Inhibition of potassium-evoked release of cholecystokinin from rat caudate-putamen, cerebral cortex and hippocampus incubated in vitro by phencyclidine and related compoundsL R Allard, J S Brog, J C Viereck, et al.
Pageof 17

Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
The Journal of Endocrinology|July 1, 1989
Opioid receptors on cells of the immune system: evidence for delta- and kappa-classesD J Carr, B R DeCosta, C H Kim, et al.
Peptides|November 1, 1992
Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that mu ligands are noncompetitive inhibitors of the delta cx opioid peptide binding siteR B Rothman, A Mahboubi, V Bykov, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2000
N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindoleA Coop, A E Jacobson, M D Aceto, et al.
European Journal of Pharmacology|June 8, 1989
Metaphit, an isothiocyanate analog of PCP, induces audiogenic seizures in miceE A Debler, M N Lipovac, A Lajtha, et al.
NIDA Research Monograph|January 1, 1986
Upregulation of the mu-noncompetitive delta binding site by chronic morphine administration: effect of preincubating membranes in 400 nM sodium chlorideJ A Danks, F C Tortella, V Bykov, et al.
Journal of Pharmaceutical Sciences|March 1, 1987
2,5-Dimethyl-2'-hydroxy-9 alpha- and 9 beta-(3-methylbutyl)-6,7-benzomorphans and N-substituted compounds in the 9 alpha-(3-methylbutyl) series: chemistry, pharmacology, and biochemistryA E Jacobson, K C Rice, T R Burke, et al.
Arzneimittel-Forschung|January 1, 1983
Zomepirac: preclinical narcotic abuse liability evaluationJ H Woods, A M Young, F Medzihradsky, et al.
Neuropeptides|October 1, 1988
A brief study of the selectivity of norbinaltorphimine, (-)-cyclofoxy, and (+)-cyclofoxy among opioid receptor subtypes in vitroR B Rothman, V Bykov, A Reid, et al.
European Journal of Pharmacology|January 24, 1989
Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sitesR B Rothman, V Bykov, J B Long, et al.
Brain Research|July 9, 1990
Inhibition of potassium-evoked release of cholecystokinin from rat caudate-putamen, cerebral cortex and hippocampus incubated in vitro by phencyclidine and related compoundsL R Allard, J S Brog, J C Viereck, et al.
Pageof 17